Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders.
about
Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteriaGenetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and TauopathiesMicroglial cell dysregulation in brain aging and neurodegenerationN-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's diseaseLessons from Microglia Aging for the Link between Inflammatory Bone Disorders and Alzheimer's DiseaseNeuroimmune crosstalk in the central nervous system and its significance for neurological diseasesUnlocking mechanisms in interleukin-1β-induced changes in hippocampal neurogenesis--a role for GSK-3β and TLXRole of the macrophage inflammatory protein-1alpha/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptide³H-deprenyl and ³H-PIB autoradiography show different laminar distributions of astroglia and fibrillar β-amyloid in Alzheimer brainSerum levels of S100B and NSE proteins in Alzheimer's disease patientsBiomarkers of oxidative damage and inflammation in Alzheimer's disease.Neuroinflammation not associated with cholinergic degeneration in aged-impaired brain.Phosphatidylinositol 4-phosphate 5-kinase alpha is induced in ganglioside-stimulated brain astrocytes and contributes to inflammatory responses.Cognitive Function, Progression of Age-related Behavioral Changes, Biomarkers, and Survival in Dogs More Than 8 Years OldCaffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases.Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration.CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-β plaques in an Alzheimer's disease mouse model.Protection of TGF-β1 against neuroinflammation and neurodegeneration in Aβ1-42-induced Alzheimer's disease model rats.The role of astroglia in neuroprotectionProtective effects of walnut extract against amyloid beta peptide-induced cell death and oxidative stress in PC12 cells.Genes and pathways affected by CAG-repeat RNA-based toxicity in DrosophilaDiverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses.SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer diseaseGoodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques.The Plant-Derived Chalcone 2,2',5'-Trihydroxychalcone Provides Neuroprotection against Toll-Like Receptor 4 Triggered Inflammation in MicrogliaExpression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology.The role of MAC1 in diesel exhaust particle-induced microglial activation and loss of dopaminergic neuron functionPerilla frutescens var. japonica and rosmarinic acid improve amyloid-β25-35 induced impairment of cognition and memory functionProtein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease PathologyNutraceuticals against Neurodegeneration: A Mechanistic Insight.Glial-mediated inflammation underlying parkinsonism.Ginsenoside rg3 alleviates lipopolysaccharide-induced learning and memory impairments by anti-inflammatory activity in ratsLong-term control of neuropathic pain in a non-viral gene therapy paradigm.Signal regulatory protein-beta1: a microglial modulator of phagocytosis in Alzheimer's diseasePEP-1-PON1 protein regulates inflammatory response in raw 264.7 macrophages and ameliorates inflammation in a TPA-induced animal model.Towards retinoid therapy for Alzheimer's disease.A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicity.Protective effects of Lingguizhugan decoction on amyloid-beta peptide (25-35)-induced cell injury: Anti-inflammatory effects.Water-soluble ginseng oligosaccharides protect against scopolamine-induced cognitive impairment by functioning as an antineuroinflammatory agent.Inhibition of Inflammation Mediated Through the Tumor Necrosis Factor α Biochemical Pathway Can Lead to Favorable Outcomes in Alzheimer Disease.
P2860
Q21245230-C84930C8-BFB2-4898-B22C-656CD128CB31Q26767289-3DDA47AC-6518-44EA-88A6-845C522032FFQ26800212-3CD18F16-1339-4594-9F31-E34AB27E3740Q26825619-1FADE200-221D-4423-B217-BFBBB813C076Q28085613-19AD18E2-3D61-4D93-AEF4-611D4FF772FFQ28269903-43D87AAA-D831-479B-83D9-9BDBB4032C1FQ28571565-170890AC-93A3-4DF7-A4E5-6CE08C6B6829Q30490518-9D82BE14-0470-4C2A-AB84-A317BE484021Q30542245-2F16D6C8-6032-481A-AB30-DB4D2C4B9861Q33705590-D3055401-5883-4E57-9F3E-999215599F3FQ33771834-23D9A344-6C41-4B8A-85D0-CFF86B7A7612Q34152498-CD8CC2EF-32C2-4D89-ADDE-AAFA22D04D08Q34161263-714E19B2-E77A-426B-8D9C-F0B59E3168A5Q34497887-EADC8F10-7E1D-4E5A-A75F-053530B5DC01Q34905120-7E38B04D-43DC-4795-AA91-5871041E6039Q34933261-05549481-54D0-4061-B5D4-FB4C17762CCCQ35034581-FF767707-083B-4ED9-A5EA-5A75479875D5Q35058396-DB290C3B-F950-48BA-A35F-9C453AFF0541Q35237112-B926BBAB-799B-4A1C-ABDD-289175A4B1CAQ35242946-C13E34A5-CBEB-4931-B751-988FD39B59BFQ35565702-BA9CEA1C-031D-46A5-9964-7EA1FA34C1D5Q35581445-EA5A1640-7938-4BEF-B8B8-BA037B6E03B3Q35639816-4C08224E-E622-4A6B-9939-F4D58F493CA2Q35922569-D4F6581E-8795-41D5-BD9C-49D4ABE282CCQ36424179-D7F0104E-648C-4D7F-BDD4-6F3F7CDA0786Q36611451-57426830-E504-4A86-8CB5-E095E4CE54B4Q36863858-B1A75E54-DC8E-4F3C-BC0D-AE8A977A29E0Q36936827-0E8C6C8B-D4AC-4D96-B0D6-2D5BA2A09598Q37053850-BD320C05-BD5B-437F-A506-65584802E463Q37168739-2A78E0C8-9E08-44D2-8AA4-C5C77ED56F75Q37287778-0B844C0A-9DD0-4ECC-9306-721622D638F8Q37301199-4B926F8C-4E12-4A5B-9D1F-A83C2413D4FDQ37406988-C309E59E-2606-40CC-87D8-07D8093B421CQ37462691-7D5FF83E-518C-4967-B59A-6BEB29613CD5Q37509810-C26B052B-3629-4CCC-A221-0F7D93ACFACDQ37515508-C5427F0B-A9F0-4C29-A1AB-F0A9FD640E70Q38791196-517F31F9-C3A4-47DB-A3BC-5A616F90EAFCQ39222559-90C03E7C-466C-49B9-8DB8-D44434C22A80Q39382911-B017B677-B45B-4A7A-A594-354A1CD43287Q41186266-15F2F856-8E4C-44B5-B454-06ED945EA50A
P2860
Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders.
@en
Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders.
@nl
type
label
Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders.
@en
Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders.
@nl
prefLabel
Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders.
@en
Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders.
@nl
P921
P1476
Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders.
@en
P2093
Claudia Schwab
Patrick L McGeer
P304
P577
2008-05-01T00:00:00Z